about
Anandamide attenuates Th-17 cell-mediated delayed-type hypersensitivity response by triggering IL-10 production and consequent microRNA inductionHistone modifications are associated with Δ9-tetrahydrocannabinol-mediated alterations in antigen-specific T cell responsesA key role of microRNA-29b for the suppression of colon cancer cell migration by American ginseng.The severity of experimental autoimmune cystitis can be ameliorated by anti-CXCL10 Ab treatmentUpregulation of miR21 and repression of Grhl3 by leptin mediates sinusoidal endothelial injury in experimental nonalcoholic steatohepatitis.Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitisΔ9-Tetrahydrocannabinol-mediated epigenetic modifications elicit myeloid-derived suppressor cell activation via STAT3/S100A8Δ(9) Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells.Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.Δ⁹-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells.MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitisRNA-seq Analysis of δ9-Tetrahydrocannabinol-treated T Cells Reveals Altered Gene Expression Profiles That Regulate Immune Response and Cell Proliferation.Reduction of myeloid-derived suppressor cells and lymphoma growth by a natural triterpenoid.Indoles mitigate the development of experimental autoimmune encephalomyelitis by induction of reciprocal differentiation of regulatory T cells and Th17 cells.Distinct microRNA expression profile and targeted biological pathways in functional myeloid-derived suppressor cells induced by Δ9-tetrahydrocannabinol in vivo: regulation of CCAAT/enhancer-binding protein α by microRNA-690.Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1.CD44 deletion leading to attenuation of experimental autoimmune encephalomyelitis results from alterations in gut microbiome in mice.Multifunctional self-fluorescent polymer nanogels for label-free imaging and drug delivery.Marijuana-derived Δ-9-tetrahydrocannabinol suppresses Th1/Th17 cell-mediated delayed-type hypersensitivity through microRNA regulation.Deficiency of Kruppel-like factor KLF4 in myeloid-derived suppressor cells inhibits tumor pulmonary metastasis in mice accompanied by decreased fibrocytes.Antimicrobial metallopolymers and their bioconjugates with conventional antibiotics against multidrug-resistant bacteria.Inverse correlation of expression of microRNA-140-5p with progression of multiple sclerosis and differentiation of encephalitogenic T helper type 1 cells.MDSCs drive the process of endometriosis by enhancing angiogenesis and are a new potential therapeutic target.AhR Activation Leads to Massive Mobilization of Myeloid-Derived Suppressor Cells with Immunosuppressive Activity through Regulation of CXCR2 and MicroRNA miR-150-5p and miR-543-3p That Target Anti-Inflammatory Genes
P50
Q31156796-E6B3F723-A7D2-48F5-83C9-AA76880D9707Q33846410-8584E43D-3DD4-4D0D-8F54-5A5BB67F9446Q35018193-AFB95255-4E37-46DE-A24E-6B323D2B4128Q35053243-5C00CA8F-C732-4D23-88F8-1643B125110CQ35057717-78176A53-0948-42B3-AF16-1C89FC76D31EQ35086412-61E080E9-7AB1-45BE-BF0F-2A3580518E53Q35207111-E8057913-F555-401F-ACE0-2CB06BFE51C2Q35223945-F6E4D8C3-A430-4961-AE8C-C6FF804270BFQ35613040-5D689C0F-4B36-4401-84B2-034ED964E67EQ35970488-7A82F54D-CF91-466F-A746-0C69E80A67B3Q36831790-25CA0F13-E0A1-40CF-9DCA-A92874A039F1Q37117257-8ADD3091-4A24-476E-A3D8-C813F0E7EEDBQ37235341-67954F82-736C-4008-B6A8-B59F6C8951B2Q37318879-0B55517C-0839-4AF8-B627-E6E3BB8C2611Q37415572-1B1D628D-3E77-4473-97D6-71460DCB2446Q37644978-31C0A1B6-BFBB-4C2D-A6E3-DF785B0CF9ABQ38764574-D291C5C7-0F81-463D-AEE6-BDCBB773A09CQ39238204-7F3F143E-AF3D-4EB0-9DC2-E9C2CB7723D1Q41486650-FD9713D2-960B-478E-963E-08C259B903DEQ42536239-39B9C433-A35F-497C-9051-8C37E9E125D1Q43916975-6F3987F2-1512-4EDE-9DCB-B3D33B688A94Q48066089-1885B7AA-5595-4217-B539-50958C541323Q49823118-3B6B42C2-39E3-4B38-864A-86F588D8A244Q93161199-1EF3D3CD-305C-48BB-9270-3D75866A95DE
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mitzi Nagarkatti
@ast
Mitzi Nagarkatti
@en
Mitzi Nagarkatti
@es
Mitzi Nagarkatti
@nl
type
label
Mitzi Nagarkatti
@ast
Mitzi Nagarkatti
@en
Mitzi Nagarkatti
@es
Mitzi Nagarkatti
@nl
prefLabel
Mitzi Nagarkatti
@ast
Mitzi Nagarkatti
@en
Mitzi Nagarkatti
@es
Mitzi Nagarkatti
@nl
P106
P31
P496
0000-0002-5977-5615